Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to $50.3 million.

  • Neuroone Medical Technologies' Shares Outstanding (Weighted Average) rose 6321.4% to $50.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.3 million, marking a year-over-year increase of 6321.4%. This contributed to the annual value of $40.2 million for FY2025, which is 5003.47% up from last year.
  • As of Q4 2025, Neuroone Medical Technologies' Shares Outstanding (Weighted Average) stood at $50.3 million, which was up 6321.4% from $40.2 million recorded in Q3 2025.
  • Neuroone Medical Technologies' 5-year Shares Outstanding (Weighted Average) high stood at $50.3 million for Q4 2025, and its period low was $10.7 million during Q3 2021.
  • For the 5-year period, Neuroone Medical Technologies' Shares Outstanding (Weighted Average) averaged around $23.6 million, with its median value being $17.8 million (2023).
  • As far as peak fluctuations go, Neuroone Medical Technologies' Shares Outstanding (Weighted Average) skyrocketed by 10053.97% in 2021, and later skyrocketed by 138.93% in 2023.
  • Over the past 5 years, Neuroone Medical Technologies' Shares Outstanding (Weighted Average) (Quarter) stood at $15.4 million in 2021, then grew by 5.34% to $16.2 million in 2022, then surged by 47.84% to $24.0 million in 2023, then rose by 28.51% to $30.8 million in 2024, then skyrocketed by 63.21% to $50.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $50.3 million in Q4 2025, compared to $40.2 million in Q3 2025 and $48.6 million in Q2 2025.